January 29, 2018What's New
The mission of the Clinical Trials Transformation Initiative (CTTI) is To develop and drive adoption of practices that will increase the quality and efficiency of clinical trials. CTTI's 10th Year Anniversary will be celebrated in Washington on February 5-6, 2018.
Target Health Inc. has supported the CTTI Mission since joining CTTI on 8 August 2008, and we congratulate CTTI for its major contribution to the clinical trials enterprise over the past 10 years. When we joined in 2008, our friend and colleague Dr. Judith Kramer wrote this in response to our commitment to join: Likewise; I really enjoyed our conversation. I am very pleased that you decided to join CTTI as I think you will be an extremely valuable participant at the "table".
As part of Target Health commitment to the CTTI Mission, Jules Mitchel, President of Target Health was honored to serve on the Executive Committee of CTTI representing the Steering Committee, and was one of the authors of the 2011 publication on "Monitoring the quality of conduct of clinical trials: a survey of current practices." This seminal CTTI publication was coauthored by: Briggs W Morrison, Chrissy J Cochran, Jennifer Giangrande White, Joan Harley, Cynthia F Kleppinger, An Liu, Jules T Mitchel, David F Nickerson, Cynthia R Zacharias, Judith M Kramer, James D Neaton. The esteemed Target Health software development team also created the database used to collect the survey information.
A major highlight last year was a joint NIH Collaboratory Grand Rounds Webinar presented with John Laschinger, CDRH/FDA and Jules Mitchel: entitled CTTI Registry Trials Project: Evaluation and Design of Registries for Conducting Clinical Trials.
Current projects that Target Health is actively involved with include Mobile Devices and Registries. There is an interview of Dr. Mitchel on the CTTI website.
Here is what we wrote in ON TARGET in 2008:
Target Health is pleased to announce that it has joined the Clinical Trials Transformation Initiative (CTTI).
CTTI, a public-private partnership with FDA's Office of Critical Path Programs and Duke University, is mandated to bring together all interested stakeholders in order to identify practices that, through broad adoption, will increase the quality and efficiency of clinical trials. It is envisioned that this group will seek out new methods and technologies that improve safety, enhance the quality of information from trials, and make the research process more efficient. CTTI will identify best practices, conduct empirical research, and develop new standards for future research efforts. .
For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors.
Joyce Hays, Founder and Editor in Chief of On Target
Jules Mitchel, Editor